NCT05960578View on ClinicalTrials.gov

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 23, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

December 31, 2027

Conditions
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma
Interventions
DRUG

Apalutamide

Given PO

PROCEDURE

Biopsy

Undergo tumor biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Computed Tomography

Undergo CT scan

DRUG

Golimumab

Given SC

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

PSMA PET Scan

Undergo PSMA PET

PROCEDURE

Bone Scan

Undergo bone scan

Trial Locations (1)

98109

RECRUITING

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

University of Washington

OTHER